drugset / Trial / NCT00197288

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

NCT00197288

Phase 3 Completed 1847 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to compare two licensed influenza vaccines (Fluzone and Fluarix) in terms of the immune response elicited and the safety/ any symptoms that may occur for up to six months after vaccination.

Timeline

Start
2005-10
Primary completion
2006-05
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular

Indications